In 2023, ESMO published the results of the “ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe” in Annals of Oncology (Bayle et al.).
The Cancer Medicines Committee are now looking to expand the survey globally to provide a broader perspective and assessment of the availability and accessibility of biomolecular technologies. In addition, they will also be running a focused study on liquid biopsy and the availability and implementation challenges.
We would like to invite all National Societies to nominate 2 medical oncologists to provide data for your country
Ansøgere bedes sende motiveret ansøgning samt CV til DSKO inden den 5. maj.
De udvalgte får direkte besked